Company page

Innovent Biologics, Inc.

Innovent Biologics, Inc. is a publicly traded company on the Hong Kong Stock Exchange under the ticker 1801. The company has a market capitalization of approximately HKD 16.6 billion. Innovent focuses on the development and commercialization of innovative therapies for cancer and other diseases.